Urban Košak

900 total citations
17 papers, 593 citations indexed

About

Urban Košak is a scholar working on Pharmacology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Urban Košak has authored 17 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Computational Theory and Mathematics and 6 papers in Organic Chemistry. Recurrent topics in Urban Košak's work include Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (9 papers) and Medicinal Plants and Neuroprotection (6 papers). Urban Košak is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (9 papers) and Medicinal Plants and Neuroprotection (6 papers). Urban Košak collaborates with scholars based in Slovenia, France and Germany. Urban Košak's co-authors include Stanislav Gobec, Janko Kos, Anja Pišlar, Boris Brus, Jacques‐Philippe Colletier, Nicolas Coquelle, Jure Stojan, Damijan Knez, Samo Turk and Xavier Brazzolotto and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Pharmacology & Therapeutics.

In The Last Decade

Urban Košak

16 papers receiving 590 citations

Peers

Urban Košak

PHARM

CTM

CAM

Kelvin D.G. Wang China

Avanish Tripathi India

Tuba Tüylü Küçükkılınç Türkiye

Slávka Hamuľaková Slovakia

Anna Horova Czechia

Zahra Najafi Iran

Ľubica Múčková Czechia

Óscar M. Bautista‐Aguilera Spain

Mohamed Benchekroun France

Zhipei Sang China

Kelvin D.G. Wang China

Urban Košak

371 ×0.8

PHARM

204 ×0.6

CTM

181 ×0.7

156 ×0.8

105 ×1.0

CAM

Citations per year, relative to Urban Košak Urban Košak (= 1×) peers Kelvin D.G. Wang

Countries citing papers authored by Urban Košak

Since Specialization

Citations

This map shows the geographic impact of Urban Košak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urban Košak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urban Košak more than expected).

Fields of papers citing papers by Urban Košak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urban Košak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urban Košak. The network helps show where Urban Košak may publish in the future.

Co-authorship network of co-authors of Urban Košak

This figure shows the co-authorship network connecting the top 25 collaborators of Urban Košak. A scholar is included among the top collaborators of Urban Košak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urban Košak. Urban Košak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Harvey, Brian H., Stanislav Gobec, Mohammed Shahid, et al.. (2025). A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade. Biomedicine & Pharmacotherapy. 187. 118093–118093. 2 indexed citations

Košak, Urban, Damijan Knez, Anja Pišlar, et al.. (2025). Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease. Chemico-Biological Interactions. 420. 111670–111670.

Košak, Urban, Damijan Knez, Anja Pišlar, et al.. (2025). N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors. Chemico-Biological Interactions. 420. 111681–111681. 1 indexed citations

Knez, Damijan, et al.. (2024). Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease. Pharmacology & Therapeutics. 264. 108748–108748. 2 indexed citations

Knez, Damijan, Izidor Sosič, Janez Mravljak, et al.. (2022). Repurposing of 8‐Hydroxyquinoline‐Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors. ChemMedChem. 17(5). e202100694–e202100694. 6 indexed citations

Chen, Xinyu, Urban Košak, Damijan Knez, et al.. (2021). Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase. Molecular Imaging and Biology. 23(4). 505–515. 5 indexed citations

Mihevc, Sonja Prpar, Urban Košak, Ilija German Ilić, et al.. (2021). Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor. Scientific Reports. 11(1). 18098–18098. 19 indexed citations

Košak, Urban, Damijan Knez, Marko Jukič, et al.. (2020). N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents. European Journal of Medicinal Chemistry. 197. 112282–112282. 43 indexed citations

Mihevc, Sonja Prpar, Urban Košak, Ilija German Ilić, et al.. (2020). Treatment of Canine Cognitive Dysfunction With Novel Butyrylcholinesterase Inhibitor. SSRN Electronic Journal. 2 indexed citations

10.

Pajk, Stane, Damijan Knez, Urban Košak, et al.. (2020). Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 498–505. 20 indexed citations

11.

Košak, Urban, Boris Brus, Damijan Knez, et al.. (2017). The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity. Journal of Medicinal Chemistry. 61(1). 119–139. 131 indexed citations

12.

Knez, Damijan, Matej Sova, Urban Košak, & Stanislav Gobec. (2017). Dual Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’S Disease. Future Medicinal Chemistry. 9(8). 811–832. 48 indexed citations

13.

Košak, Urban, Damijan Knez, Nicolas Coquelle, et al.. (2016). N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer’s agents. Bioorganic & Medicinal Chemistry. 25(2). 633–645. 56 indexed citations

14.

Brus, Boris, Urban Košak, Samo Turk, et al.. (2014). Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor. Journal of Medicinal Chemistry. 57(19). 8167–8179. 243 indexed citations

15.

Košak, Urban, Boris Brus, & Stanislav Gobec. (2014). Straightforward synthesis of orthogonally protected piperidin-3-ylmethanamine and piperidin-4-ylmethanamine derivatives. Tetrahedron Letters. 55(12). 2037–2039. 11 indexed citations

16.

Košak, Urban, et al.. (2014). Convenient syntheses of orthogonally protected aminocyclopentitols from aldopentoses. Tetrahedron Letters. 56(3). 529–531. 3 indexed citations

17.

Gobec, Stanislav, Urban Košak, & Andreja Kovač. (2012). One-Pot Synthesis of β-Keto Esters and Preparation of 3-Ketopalmitoyl-CoA. Synlett. 23(11). 1609–1612. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact